Lifestyle Guidance Methods in NAFLD

The Investigation of Different Guidance Methods to Facilitate Lifestyle Changes in Patients With NAFLD

NCT05792488•Ziekenhuis Oost-Limburg

View on ClinicalTrials.gov

Summary

To determine the efficiency of lifestyle modification (due to a dietitian or digital application) compared to standard of care.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•NAFLD based in FibroScan measurements

Exclusion Criteria

•excessive alcohol use
•other causes of liver disease
•secondary causes of liver steatosis

Locations (1)

Ziekenhuis Oost-Limburg

Genk, Limburg, Belgium

Key Dates

Start Date

October 24, 2022

Primary Completion Date

March 31, 2025

Completion Date

March 31, 2025

Last Updated

July 9, 2025

Enrollment

300

ACTUAL participants

Conditions

Non-Alcoholic Fatty Liver Disease

Interventions

Coach

BEHAVIORAL

App

BEHAVIORAL

Standard of care

OTHER

Identification of Liver Fibrosis Biomarkers

NCT06819917

Non-alcoholic Fatty LiverNon-Alcoholic Fatty Liver Disease+1 more

View study

RECRUITINGPHASE3

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

NCT07221227

Non-alcoholic Fatty Liver Disease

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 9, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

RECRUITING